Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia

Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. He earned his Ph.D. in Pharmaceutical Sciences in 2013 and has over 20 years of academic experience. Dr. Kapoor has published 175+ research and review articles and contributed 50 book chapters. He is currently editing 18 international books with leading publishers and supervises four Ph.D. students in nanodrug delivery and modified release systems. His editorial roles include Associate Editor for Naunyn-Schmiedeberg’s Archives of Pharmacology, PLOS ONE, and several Frontiers journals, and Consulting Editor for Cytotechnology. He has reviewed manuscripts for 135+ journals and holds eight design patents. Dr. Kapoor has secured research and event grants from GUJCOST, GSBTM, and AICTE-ATAL, delivered 20+ invited talks, and actively participates in national conferences and workshops. . Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.

• 1. Introduction2. siRNA and miRNA therapies for leukaemia3. Gene therapy for leukaemia4. Exploring Polymeric nanoparticles in leukaemia management5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications10. Advances in Leukemia Treatment using Micelles and Dendrimers11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy12. Biological and immunological aspects of nanocarriers and nano-vaccines13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer